IRS - Holbæk Hospital, Research Unit of Medicine (Holbæk)

Medicine & Life Sciences

1. Meta-Analysis 100%
2. Systematic Reviews 97%
3. Randomized Controlled Trials 87%
4. Blood Pressure 52%
5. Hypertension 41%
6. Mortality 40%
7. Type 2 Diabetes Mellitus 40%
8. Nepal 36%
9. Cardiovascular Diseases 32%
10. Placebos 31%
11. Cohort Studies 30%
12. Heart Failure 29%
13. Atrial Fibrillation 23%
14. Galectin 4 20%
15. Confidence Intervals 20%
16. Quality of Life 19%
17. Delirium 19%
18. Coronary Artery Disease 18%
19. Therapeutics 18%
20. Biomarkers 16%
21. Critical Illness 16%
22. Clinical Trials 16%
23. Odds Ratio 15%
24. Pain 15%
25. Telemedicine 15%
26. Data Analysis 14%
27. Mentoring 14%
28. Patient Care 14%
29. Population 14%
30. Exercise 14%
31. Health 14%
32. Brain Natriuretic Peptide 13%
33. Aortic Valve Stenosis 13%
34. Myocardial Infarction 13%
35. Myocardial Ischemia 13%
36. Ivabradine 12%
37. Carbohydrate-Restricted Diet 12%
38. Extremely Premature Infants 12%
39. Equipment and Supplies 11%
40. Diphosphonates 11%
41. Carotid Intima-Media Thickness 11%
42. Sepsis 11%
43. Denmark 11%
44. Osteogenesis Imperfecta 11%
45. Child 11%
46. Neonatal Sepsis 11%
47. Opioid Analgesics 11%
48. Anti-Bacterial Agents 10%
49. Ibuprofen 10%
50. Out-of-Hospital Cardiac Arrest 10%
51. Dexmedetomidine 10%
52. Tramadol 10%
53. Databases 10%
54. Proton Pump Inhibitors 10%
55. Life Style 10%
56. Sildenafil Citrate 10%
57. Guidelines 10%
58. Acetaminophen 10%
59. Atrial Flutter 10%
60. Registries 10%
61. Stroke 10%
62. Osteoporotic Fractures 9%
63. Cannabinoids 9%
64. Body Mass Index 9%
65. Primary Health Care 9%
66. Obsessive-Compulsive Disorder 9%
67. Left Ventricular Hypertrophy 9%
68. Antidepressive Agents 9%
69. Fetal Growth Retardation 9%
70. Morbidity 9%
71. LCZ 696 9%
72. MEDLINE 8%
73. Chronic Pain 8%
74. Hypothermia 8%
75. Cognitive Behavioral Therapy 8%
76. Obesity 8%
77. Dexamethasone 8%
78. Knee Replacement Arthroplasties 8%
79. Urokinase Plasminogen Activator Receptors 8%
80. Postoperative Pain 8%
81. Serum 8%
82. Insulin Resistance 8%
83. C-Reactive Protein 8%
84. Research Personnel 8%
85. Osteoporosis 7%
86. Critical Care 7%
87. Logistic Models 7%
88. Population Control 7%
89. Multicenter Studies 7%
90. Ulcer 7%
91. Safety 7%
92. Equivalence Trials 7%
93. Chronic Obstructive Pulmonary Disease 7%
94. Unstable Angina 7%
95. Pregnant Women 7%
96. Fats 7%
97. Overweight 7%
98. Risk Assessment 7%
99. Intensive Care Units 7%
100. Brain Injuries 7%